INCB-057643 Uses, Dosage, Side Effects and more

INCB-057643 is under investigation in clinical trial NCT02959437 (Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)).

Trade Name INCB-057643
Generic INCB-057643
Type
Formula C20H21N3O5S
Weight Average: 415.46
Monoisotopic: 415.120191962
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share